Charles Hillenbrand, MD
Vascular Surgery · Olympia, WANPI 1407210206
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (58.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 64.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $7,717 and has fallen 73.8% since, to $2,025 in 2025.
Across 60 payments — averaging $213.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Globus Medical$2K
- Shockwave Medical, Inc$723
- Boston Scientific$473
- Inspiremd Ltd$340
- Bolton Medical Inc$315
- plus $539 from 4 others
What the payments were for
- Grants$7,50059%
- Travel & lodging$2,50920%
- Food & beverage$2,77422%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 9 | $8,277 |
| Globus Medical | 12 | $2,116 |
| Shockwave Medical, Inc | 4 | $723 |
| Boston Scientific | 10 | $473 |
| Inspiremd Ltd | 6 | $340 |
| Bolton Medical Inc | 4 | $315 |
| Penumbra, Inc. | 6 | $267 |
| Smith+Nephew | 6 | $183 |
| Stryker | 2 | $74 |
| Terumo Medical Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,783 in reported general payments places this provider in the 80th percentile of 111 vascular surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 28 | $268 |
| Oxycodone Hcl | 27 | $126 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Olympia
- Richard KrugOlympia$13K
- Thomas CurryOlympia$9K
- Sara WasilenkoOlympia$7K
- Robert PerryOlympia$6K
- Benjamin StarnesSeatle$666K
- Kathleen GibsonBellevue$593K
- Brian FerrisBellevue$170K
- Sara ZettervallSeattle$126K
- Paul HayesSeattle$83K
- Elina QuirogaSeattle$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.